about
Hypothyroidism and its rapid correction alter cardiac remodelingMuRF1 mono-ubiquitinates TRα to inhibit T3-induced cardiac hypertrophy in vivo.Thyroid hormone promotes remodeling of coronary resistance vessels.Low-dose T₃ replacement restores depressed cardiac T₃ levels, preserves coronary microvasculature and attenuates cardiac dysfunction in experimental diabetes mellitus.mTOR attenuates the inflammatory response in cardiomyocytes and prevents cardiac dysfunction in pathological hypertrophy.Longstanding hyperthyroidism is associated with normal or enhanced intrinsic cardiomyocyte function despite decline in global cardiac function.Thyroid hormone replacement therapy attenuates atrial remodeling and reduces atrial fibrillation inducibility in a rat myocardial infarction-heart failure modelThyroid and the heartHigher Thyroid-Stimulating Hormone, Triiodothyronine and Thyroxine Values Are Associated with Better Outcome in Acute Liver Failure.Long-term physiological T3 supplementation in hypertensive heart disease in ratsHypothyroidism as a risk factor for development of cardiovascular disease in patients with rheumatoid arthritis.Effect of Hypothyroidism and Hyperthyroidism on Tissue Thyroid Hormone Concentrations in Rat.Restoration of cardiac tissue thyroid hormone status in experimental hypothyroidism: a dose-response study in female rats.Iodinated Contrast Medium Exposure During Computed Tomography Increase the Risk of Subsequent Development of Thyroid Disorders in Patients Without Known Thyroid Disease: A Nationwide Population-Based, Propensity Score-Matched, Longitudinal Follow-UpBoth hypothyroidism and hyperthyroidism increase atrial fibrillation inducibility in ratsClinical characteristics and outcomes of myxedema coma: Analysis of a national inpatient database in Japan.Red alert for women's heart: the urgent need for more research and knowledge on cardiovascular disease in women: proceedings of the workshop held in Brussels on gender differences in cardiovascular disease, 29 September 2010.Chronic heart failure: current evidence, challenges to therapy, and future directions.Phosphoinositide-3 kinase signaling in cardiac hypertrophy and heart failureThyroid hormone and cardiac repair/regeneration: from Prometheus myth to reality?Prevalence and importance of comorbidities in patients with heart failure.Experimental biomarkers in heart failure: an update.Thyroid hormone and cardiovascular system: from basic concepts to clinical application.Nonthyroidal illness and the cardiorenal syndrome.Thyroid hormones and the heart.Role of thyroid hormones in ventricular remodeling.Translating thyroid hormone effects into clinical practice: the relevance of thyroid hormone receptor α1 in cardiac repair.Mitochondria as key targets of cardioprotection in cardiac ischemic disease: role of thyroid hormone triiodothyronine.Thyroid function in critically ill patients.Cardiac Thyroid Hormone Metabolism and Heart Failure.Establishing a pragmatic framework to optimise health outcomes in heart failure and multimorbidity (ARISE-HF): A multidisciplinary position statement.Thyroid Hormone and Cardioprotection.The search for efficient diagnostic and prognostic biomarkers of heart failure.Effects of short-term levothyroxine therapy on myocardial injuries in patients with severe overt hypothyroidism: Evidence from a cardiac MRI Study.Biomarkers of Heart Failure with Preserved and Reduced Ejection Fraction.New insights into mechanisms of cardioprotection mediated by thyroid hormones.Effects of commonly used inotropes on myocardial function and oxygen consumption under constant ventricular loading conditions.Early and short-term triiodothyronine supplementation prevents adverse post-ischemic cardiac remodeling: role of transforming growth factor-β1 and anti-fibrotic miRNA signaling.Hormonal Profile in Patients With Dilated Cardiomyopathy.Increased left atrial pressure in non-heart failure patients with subclinical hypothyroidism and atrial fibrillation
P2860
Q27339180-10302A4D-39FF-482A-A7B9-59F2B628DA48Q33752237-F13D1F48-844C-443A-859A-B55C3FC80589Q34037938-58ABC408-8AC8-4A29-A887-FA232C84A04FQ34129773-CA222AAB-20A2-480C-93B4-41F8A1428806Q34426387-90067BCA-5CF0-4135-B864-B82AEDF536B3Q34441808-20FA1927-0A98-4815-B263-E2C7ABF56A60Q34602635-1808D087-5065-4E84-AEE5-0D22A41EA28FQ35054125-225608FF-64C4-4C15-A8C9-E4A2734A32ABQ35684045-BCE52FA0-EAEE-4656-83AE-527763C1A9DDQ36114071-E6DABEE8-95C8-40CE-8ED9-FA929C121E10Q36456316-E7354CEE-C8C5-41BB-9EA9-C3FA4D349FADQ36811305-CC9A01F4-1597-456E-85E1-277289C30C69Q36946056-6D1384F0-72D9-44F5-BE0B-7346FC5D6CE5Q37328376-91E97E4D-0A02-4D22-A203-561ACDF9D1D9Q37680664-21936BA8-7240-4C14-9694-E1FE474C9912Q37700266-0AC79C0B-4ECB-4C42-ACFB-70652A80E8BAQ37853272-D9F7C021-6330-4F27-8056-8202820E609BQ37880858-5652F992-5E3C-4CDA-A22F-C1457A2913B9Q37883418-E24FE722-4084-46C5-A1A5-1ADBC9E2529FQ38023872-C049388B-B63C-4733-94CA-7509A1932665Q38037383-9E4B2E6C-0A5F-4FC1-8D58-13DC06F948AAQ38055505-0C94A583-97DD-45A3-B8A5-55B271B32BC4Q38084174-D5599244-2403-41EC-968D-65B2F2C4468BQ38133714-3FDDA2DB-8A4C-4005-ABBA-2F55803A933EQ38267475-EB513816-7740-48F9-A0EF-1EBDB66FAD52Q38285918-D603D05A-93BB-4353-B04D-48636DBB3245Q38287099-17258BE0-8178-4F36-904D-95E5155EE3E7Q38391278-7F98747E-862A-40D7-B881-493972A86A81Q38527069-4198EA73-9F61-46EF-911B-08EA83212B24Q38635787-E6A3F0F6-FD07-42CF-B0DE-0D99F2B2DAF2Q38789122-409EE88C-6B53-41BA-A820-A531EFA5E05FQ38878221-C6172730-DAFB-4393-A0A7-630DA8AA5A7BQ38879246-F12E7D0B-0FDD-4BF7-9512-69F0B4118E5BQ38890676-93E92C39-5A1A-4BE6-B8FD-6AF82609E5BAQ39127729-7CF420DD-9EEF-4F17-AFFA-47F4D2351838Q39299996-62DB3B63-845C-4C72-BDEF-E5EAA544BE1AQ39790530-5EDE8C90-646B-448F-B7B5-9888A75A6328Q39800297-D7B60060-79BF-4A4A-83FC-BDF07CCAFAFCQ40452602-A72F90D9-6C5B-4179-BBCE-B176A6D13C4AQ40965001-5915895A-9051-47EC-A346-1050FA6CBCBB
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Thyroid replacement therapy and heart failure.
@ast
Thyroid replacement therapy and heart failure.
@en
Thyroid replacement therapy and heart failure.
@nl
type
label
Thyroid replacement therapy and heart failure.
@ast
Thyroid replacement therapy and heart failure.
@en
Thyroid replacement therapy and heart failure.
@nl
prefLabel
Thyroid replacement therapy and heart failure.
@ast
Thyroid replacement therapy and heart failure.
@en
Thyroid replacement therapy and heart failure.
@nl
P1433
P1476
Thyroid replacement therapy and heart failure.
@en
P2093
Anthony Martin Gerdes
Giorgio Iervasi
P304
P356
10.1161/CIRCULATIONAHA.109.917922
P407
P577
2010-07-01T00:00:00Z